Healthy Extracts ( (HYEX) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Healthy Extracts Inc. has filed a Form 12b-25 announcing a delay in submitting its Form 10-K (Yearly Report) for the financial year ended December 31, 2025. The company confirmed that all other required reports over the past 12 months have been filed on time, limiting this delay to the latest annual filing.
Management attributes the postponement primarily to complications arising from its late third-quarter 2025 acquisition of Gummy USA LLC. Key operational data and information related to this acquired business have been unavailable, making it impractical to complete the consolidated annual report without incurring unreasonable effort or expense.
Healthy Extracts Inc. has stated that it intends to file the Form 10-K (Yearly Report) no later than the fifteenth calendar day following the original due date. This timeline aligns with the grace period allowed under SEC Rule 12b-25 for late annual filings.
The company does not expect any significant change in results of operations compared with the prior fiscal year, based on what it knows today. Investors should remember that these expectations are forward-looking in nature and could change once the final numbers, including the impact of Gummy USA LLC, are fully compiled and reviewed.
Healthy Extracts Inc. emphasizes its intent to remain compliant with SEC reporting rules while it completes the integration of newly acquired data. The notification was signed on March 31, 2026, by President Kevin “Duke” Pitts, underscoring executive-level oversight of the delayed filing and the company’s ongoing reporting obligations.
The most recent analyst rating on (HYEX) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Healthy Extracts stock, see the HYEX Stock Forecast page.
Spark’s Take on HYEX Stock
According to Spark, TipRanks’ AI Analyst, HYEX is a Neutral.
The score is held down primarily by weak financial performance: despite a sharp revenue rebound and improved gross margin, HYEX remains unprofitable and has returned to TTM cash burn, with leverage/solvency assessment constrained by incomplete TTM balance-sheet fields. Technicals are mildly supportive with price above key moving averages and a positive MACD, but valuation is difficult to justify with a negative P/E and no dividend yield.
To see Spark’s full report on HYEX stock, click here.
More about Healthy Extracts
Average Trading Volume: 1,022
Technical Sentiment Signal: Strong Sell
Current Market Cap: $25.73M
See more data about HYEX stock on TipRanks’ Stock Analysis page.